Clinical Trials Browser

INDUSTRY × Gemcitabine × Other solid neoplasm × Clear all

Mesothelioma, Malignant

Advanced Solid Tumour

Locally Advanced or Metastatic Solid Tumours

Adult Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumors

Solid Tumors

Advanced Solid Tumours

Advanced Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumor

Solid Tumors

Advanced Solid Tumor

Advanced Solid Tumors

Advanced Solid Tumors

Metastatic Solid Tumors

Advanced Solid Tumors

Solid Tumors

Solid Tumors

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumor

Solid Tumors

Solid Tumors

Solid Tumors

Solid Tumors

Malignant Neoplasmas

Advance Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Solid Tumors

Mesothelioma

Clinical Trials

INFINITE

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

TRESR

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

MK-1775-001

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

HLX07Ib/II

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

M6620 First in Human Study

A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors

PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors

Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma